arBtrage CAPITALIZING MARKETS checking… Sign in

Olema Pharmaceuticals, Inc.

OLMA Health Care Biotechnology: Pharmaceutical Preparations
$10.31
▼ -3.5% Today
as of Jun 7, 07:23 ET
Last 30 days -29.34% Apr 28 → Jun 05
$9.92 $11.33 $12.75 $14.17 $15.58 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$10.60
High
$10.75
Low
$10.02
Volume
$2M
Avg Vol
$2M
Mkt Cap
$1.1B
P/E (TTM)
Beta
52w High
$36.26
52w Low
$3.89
Div Yield
Shares Out
$87M

Overview

52-week range
$3.89
$36
20% of range
Avg surprise (last 2)
+13.3%
Avg reaction (last 2)
-3.8%
0% positive
Latest IV / EM
350%
EM ±48.5% · $10 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.60$-0.54$-0.48$-0.42$-0.36 Actual $-0.49Actual $-0.48Actual $-0.56Actual $-0.54Actual $-0.60Actual $-0.36Est $-0.49Actual $-0.51Actual $-0.49Actual $-0.52Est $-0.52 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-53M$-48M$-42M$-37M$-32M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.52 $-0.52 0.0% -44.4% -6.0% earnings
Tue Sep 30, 2025Sep 2025 $-0.49 financials
Mon Jun 30, 2025Jun 2025 $-0.51 financials
Tue May 13, 2025Mar/2025 $-0.36 $-0.49 +26.5% -1.7% earnings
Mon Sep 30, 2024Sep 2024 $-0.60 financials
Sun Jun 30, 2024Jun 2024 $-0.54 financials
Sun Mar 31, 2024Mar 2024 $-0.56 financials
Sat Sep 30, 2023Sep 2023 $-0.48 financials
Fri Jun 30, 2023Jun 2023 $-0.49 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-58M$-46M$-48M$-35M$-38M$-34M
Net income$-53M$-42M$-44M$-30M$-35M$-30M
EPS (diluted)$-0.52$-0.49$-0.51$-0.36$-0.60$-0.54

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$53M$48M$35M$52M$51M$139M$36M$17M
Inventory
Total current assets$513M$515M$334M$368M$397M$438M$218M$242M
Total assets$531M$533M$352M$382M$410M$451M$230M$255M
Long-term debt
Total liabilities$50M$55M$45M$37M$26M$42M$31M$27M
Total equity$480M$479M$307M$345M$383M$409M$199M$227M

Implied volatility — last 90 days

345%347%350%352%355% Jun 07 — IV 350% · EM ±48.5%

Sector peers